VerifyMe Technologies to Combat World-Wide Counterfeit Drug Epidemic

- VerifyMe, Inc. (OTCQB:VRME), a digital technology solutions provider specializing in counterfeit prevention, authentication, serialization, data mining, track and trace, features for labels, packaging and products, is pleased to announce that it has entered into a strategic relationship with Techind Engineers & Consultants-Impex ("Techind"), part of the Gohar Group, of India.

Techind has experience in serialization and track and trace, having sold and installed more than 100 production line serialization systems for 10 clients in the Pharmaceutical industry over the past few years.

VerifyMe and Techind will work together in providing the VeriPAS(TM) serialization and track and trace solution to the broad range of industries and clients of Techind, with specific focus on the Pharmaceutical industry. Other project areas of Techind include: Bio-technology, Processed Food, Chemicals and Allied Packaging up to tertiary stage, on a turnkey basis. With 35+ years of presence in the market, Techind has earned its position, trust and goodwill in the region.

Techind's CEO A.J.S Gohar stated, "We have experience in serialization and track and trace over the past 9 years as our clients have asked for product authentication and brand protection solutions. VerifyMe's VeriPAS is an upgrade from what we were previously doing and something we believe our existing clients can integrate with and new clients will desire.

We have already highlighted the areas of pharmaceutical, nutraceutical and consumer products, where we have clients and relationships that seek serialization and track and trace solutions. This partnership is particularly timely given our experience in the pharma industry and recent avenues to serialize and authenticate COVID-19 test kits.

We have experience in serialization and track and trace over the past 9 years as our clients have asked for product authentication and brand protection solutions.

This will be an immediate area of focus. We look forward to rolling out VeriPAS to our client base in India, the SAARC region, and worldwide."

VerifyMe Chief Executive Officer Patrick White commented, "According to the World Health Organization, people are dying in the tens of thousands from the scourge of counterfeit drugs. See https://pr.report/ylAwH8q9. People want comfort that the drugs and medications they are taking are authentic. Our technologies allow both users and brand inspectors to perform a simple instant effective authentication test with their smart phone. We are thrilled to have our technologies chosen by the Gohar Group and Techind. Combining our counterfeit protection technologies with their expertise in building pharmaceutical manufacturing systems is a win not only for their pharmaceutical clients but for the people that need to be protected from harmful and deadly counterfeit drugs. Their business success and impeccable reputation, not only in India and the SAARC region, but worldwide, represent an opportunity for our serialization and track and trace solution, VeriPAS. Their client list is extremely impressive and particularly in pharma, represents great opportunity for us potentially with the likes of Sun Pharma, Cipla, Lupin, Panacea Biotec, Wockhardt, Intas, Apotex, Hospira, Johnson & Johnson, Daiichi Sankyo, Sanofi Aventis, Glaxo Smithkline, Novartis, Merck, Pfizer and AstraZeneca. We also look forward to working with Mr. Adhinayak Gohar - Director Technical of Techind in making our world a safer place."